Reduction in Absolute Neutrophil Counts in Patient on Clozapine Infected with COVID-19
Open Access
- 27 October 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (21) , 11289
Abstract
Despite its severe adverse effects, such as agranulocytosis, clozapine is the primary treatment for treatment-resistant schizophrenia. The established clozapine monitoring system has contributed to reducing agranulocytosis incidence and mortality rates. However, the pandemic coronavirus disease 2019 (COVID-19) has caused changes in the monitoring system. This review aimed to assess the current evidence on the neutrophil changes in the patient on clozapine treatment and infected with COVID-19. Individual cases reported various absolute neutrophil count (ANC) levels, normal, reduced, or elevated. No agranulocytosis case was reported. One case had a borderline moderate-severe ANC level, but the patient was in the 18-week period of clozapine treatment. A cumulative analysis of case the series initially reported inconclusive results. However, a more recent study with a larger sample size reported a significant reduction in the ANC during COVID-19 infection. Nevertheless, this effect is transient as no significant difference was found between the baseline and the post-infection period in ANC levels. In conclusion, COVID-19 is associated with a temporary reduction in ANC levels. The results supported the recommendation to reduce the frequency of clozapine monitoring in the eligible candidates. However, more data are required to confirm the current findings given the limitations, including study design, sample size, and statistical analysis.Keywords
Funding Information
- Faculty of Medicine, Univeristi Kebangsaan Malaysia (FF-2021-055)
This publication has 40 references indexed in Scilit:
- Effect of Clozapine and Olanzapine on Neutrophil Kinetics: Implications for Drug-Induced AgranulocytosisChemical Research in Toxicology, 2014
- The STARD9/Kif16a Kinesin Associates with Mitotic Microtubules and Regulates Spindle Pole AssemblyCell, 2011
- Impact of Infectious and Inflammatory Disease on Cytochrome P450–Mediated Drug Metabolism and PharmacokineticsClinical Pharmacology & Therapeutics, 2009
- Blockade of Interleukin 6 Signaling Induces Marked Neutropenia in Patients with Rheumatoid Arthritis: Figure 1.The Journal of Rheumatology, 2009
- G-CSFR Ubiquitination Critically Regulates Myeloid Cell Survival and ProliferationPLOS ONE, 2008
- The history of clozapine and its emergence in the US marketHistory of Psychiatry: Madness, Science, Culture, 2007
- Clozapine bioactivation induces dose-dependent, drug-specific toxicity of human bone marrow stromal cells: A potential in vitro system for the study of agranulocytosisBiochemical Pharmacology, 2006
- Clozapine, agranulocytosis, and benign ethnic neutropeniaPostgraduate Medical Journal, 2005
- Mechanism of Clozapine-Induced AgranulocytosisCNS Drugs, 1997
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988